精品三级国产精品经典三-精品三级国产一区二区三区四区-精品三级久久久久久久电影-精品三级三级三级三级三级-正在播放一区-正在播放亚洲一区

技術文章您現在的位置:首頁 > 技術文章 > Broadpharm提供可切割和不可切割Linker

Broadpharm提供可切割和不可切割Linker

更新時間:2023-08-28   點擊次數:894次

Antibody-Drug Conjugates (ADCs) are composed of a drug (payload) and antibody (mAbs) that are bound using linkages that are specifically designed to deliver the payload to the intended target environment. ADCs are designed to sparing healthy cells by targeting specific cancer types.

This article expands upon the linker information in the ADC Linker Technology in 2021 article. Specifically, the cleavable and non-cleavable categories of ADC linkers. Cleavable linkers use inherent properties of tumor cells for selective release of payloads from the ADCs. There are three commonly used mechanisms for cleavable linkers; protease-sensitive peptide linkers, acid sensitive hydrazone linkers, and glutathione-sensitive disulfide linkers.

Protease-sensitive cleavable linkers use the dominant proteases found in tumor cell lysosomes for recognition and cleavage of a specific peptide sequence in the linker. A commonly used ADC linker makes use of a valine-citrulline (vc) dipeptide, first discovered by Dubowchik et al., as an intracellular cleavage mechanism by cathepsin B.

diagram of adcetris
Figure 1. Adcetris with enzymatically cleavable val-cit linkage.

Acid-sensitive linkers use a lower pH in the endosomal (pH = 5-6) and lysosomal (pH = 4.8) compartments, in contrast to cytosol (pH = 7.4) to trigger hydrolysis of acid labile groups within a linker such as hydrazone.

Glutathione-sensitive linkers use higher concentrations of intracellular glutathione that in the plasma. This causes disulfide bridges to release the payload upon reduction by glutathione.

Cleavable linkers may also help with destroying cancer cell adjacent to their targets through a process referred to as "bystander effect". The bystander effect occurs when the payload is released near the targeted cancer cell, or a payload diffuses out of one cancer cell and then is absorbed by a second cancer cell.

Non-cleavable linkers only degrade when the anti-body degrades. Release of the payload occurs mainly in the lysosome after internalization of the ADC and degradation of both the antibody and linker. This may be an advantage since it could lead to a lower risk of systemic toxicity. Figure 2 shows an example of Kadcyla, which uses SMCC crosslinker as the non-cleavable linker.

diagram of kadcyla
Figure 2. Kadcyla, shown with the linker in green and the payload in orange, was designed with a non-cleavable linkage.

BroadPharm offers a wide array of different ADC Linkers, PEG Linkers to empower our customer's advanced research worldwide. These compounds feature great aqueous solubility, smart choice of PEG length, and a broad selection of functional groups to choose from.

Journal Reference:

1.Editorial Team, "FDA Grants Accelerated Approval for Sacituzumab Govitecan in Metastatic Triple-negative Breast Cancer", ADC Review (2020)

2.FDA Press Release, "FDA grants accelerated approval to loncastuximab tesirine-lpyl for large B-cell lymphoma", (2021)

3.Staudacher, Brown, "Antibody drug conjugates and bystander killing: is antigen-dependent internalisation required?", Br J Cancer 117, (2017): 1736-1742

    訂購咨詢

    靶點科技(北京)有限公司


靶點科技(北京)有限公司

靶點科技(北京)有限公司

地址:中關村生命科學園北清創意園2-4樓2層

© 2025 版權所有:靶點科技(北京)有限公司  備案號:京ICP備18027329號-2  總訪問量:294935  站點地圖  技術支持:化工儀器網  管理登陸

主站蜘蛛池模板: 国内精品久久久久久影院8f | 国内自拍网址 | 男人在线网址 | 99视频免费观看 | 久久精品成人免费看 | 国产一区欧美 | 免费看毛片网 | 国产三级全黄 | 亚洲欧美日本韩国综合在线观看 | 俄罗斯小屁孩cao大人免费 | 国模午夜写真福利视频在线 | 欧美人成在线视频 | 中文成人在线视频 | 久久久久久久久毛片精品 | 这里只有久久精品视频 | 在线免费观看毛片网站 | 亚洲国产精久久久久久久春色 | 日本综合久久 | 午夜宅男在线永久免费观看网 | 草草影院欧美三级日本 | 久草观看 | 免费看特级毛片 | 国产成人精品免费视频网页大全 | 中国美女一级看片 | 高清成人爽a毛片免费网站 高清大学生毛片一级 | 亚洲免费专区 | 99re66热这里只有精品免费观看 | 国产成人精品亚洲2020 | 亚洲欧美日韩国产专区一区 | 中文字幕在线播放 | 欧美成人福利视频 | 在线观看99| 欧美一区精品二区三区 | 免费高清一级欧美片在线观看 | 免费国产a国产片高清不卡 免费国产不卡午夜福在线 免费国产不卡午夜福在线观看 | 欧美一级大黄特黄毛片视频 | 性配久久久| 国产精选在线 | 亚洲超大尺度激情啪啪人体 | 色www亚洲 | 国产一级做a爰片久久毛片99 |